IP Library Granted Patent US 7,294,123
Granted Patent B2
US 7,294,123 · App. 10/738,473 · Granted Nov 13, 2007

Activatable bioactive vascular occlusive device and method of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,294,123
App. No.
10/738,473
Granted
Nov 13, 2007
Kind
B2
Abstract

A vascular occlusive device which includes a support structure and a bioactive coating disposed onto the support structure and an outer barrier coating which serves to prevent a reaction between the bioactive agent and bodily fluids until the outer barrier is activated by applying an external agent to the outer barrier.

Claims (18)

1. A method of treating an aneurysm comprising the steps of:

providing a vascular occlusive device comprising a support member, a bioactive agent disposed on said support member, and a barrier exhibiting the characteristics of normally preventing a reaction between the bioactive agent and a bodily fluid and of exposing a portion of said bioactive agent when an external agent is applied to said barrier;

inserting a delivery catheter into a blood vessel;

advancing the distal tip of the delivery catheter through the blood vessel until the distal tip is adjacent an aneurysm within the blood vessel;

delivering said vascular occlusive device with the delivery catheter into an aneurysm; and,

applying said external agent through the catheter and into the aneurysm to thereby activate said barrier to expose said bioactive agent to bodily tissue to thereby cause a reaction between the bioactive agent and the bodily tissue.

2. A method of treating an aneurysm comprising the steps of:

providing a vascular occlusive device comprising a support member having a bioactive surface which reacts with bodily tissue and having a barrier which exhibits the characteristic of normally inhibiting a reaction between said bioactive surface of said vascular occlusive device and bodily tissue;

inserting a delivery catheter into a blood vessel;

advancing the distal tip of the delivery catheter through the blood vessel until the distal tip is adjacent an aneurysm with the blood vessel;

delivering said vascular occlusive device with the delivery catheter into an aneurysm; and,

applying an external agent through the catheter and into the aneurysm to thereby activate said barrier and thus expose said bioactive surface to bodily tissue to thereby cause a reaction between the bioactive surface and the bodily tissue.

3. A method of delivering a bioactive agent to a desired location in a blood vessel comprising the steps of:

providing a support member having a bioactive surface which reacts with bodily tissue and having a barrier which exhibits the characteristic of normally inhibiting a reaction between said bioactive surface of said support member and bodily tissue;

inserting a delivery catheter into a blood vessel;

advancing the distal tip of the delivery catheter through the blood vessel until the distal tip is adjacent the desired location within the blood vessel;

delivering said support member with the delivery catheter to the desired location; and,

applying an external agent through the catheter to said support member to thereby activate said barrier and thus expose said bioactive surface to bodily tissue to thereby cause a reaction between the bioactive surface and bodily tissue.

Assignments (2)
MERGER Recorded Jul 31, 2009
From: CORDIS NEUROVASCULAR, INC.
To: CODMAN & SHURTLEFF, INC.
Reel/Frame 023032/0233 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2003
From: JONES, DONALD K.; LORENZO, JUAN A.; POMERANZ, MARK L.; SHERMAN, DARREN
To: CORDIS NEUROVASCULAR, INC.
Reel/Frame 014826/0776 →